DR REDDYS LABORATORIES
Back to Income Statement
|
DR REDDYS LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹4,507 Cr | ₹2,183 Cr | ₹1,952 Cr | ₹2,026 Cr | ₹1,950 Cr |
What is the latest Consolidated Net Profit of DR REDDYS LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹4,507 Cr |
Mar2023 | ₹2,183 Cr |
Mar2022 | ₹1,952 Cr |
Mar2021 | ₹2,026 Cr |
Mar2020 | ₹1,950 Cr |
How is Consolidated Net Profit of DR REDDYS LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹4,507 Cr | 106.52 | |
Mar2023 | ₹2,183 Cr | 11.83 | |
Mar2022 | ₹1,952 Cr | -3.67 | |
Mar2021 | ₹2,026 Cr | 3.90 | |
Mar2020 | ₹1,950 Cr | - |
Compare Consolidated Net Profit of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹110,701.3 Cr | -2.6% | 8.3% | 7.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,254.0 Cr | -2.5% | -4.9% | 8.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,374.0 Cr | -2.7% | -0.9% | 42.5% | Stock Analytics | |
CIPLA | ₹119,795.0 Cr | -1.5% | 0.1% | -4.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,218.0 Cr | -2.6% | -3.7% | 11.9% | Stock Analytics | |
MANKIND PHARMA | ₹95,866.6 Cr | -2.5% | -8.3% | 5.2% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -2.6% |
8.3% |
7.9% |
SENSEX | -0.4% |
0.2% |
5.9% |
You may also like the below Video Courses